BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28460165)

  • 1. Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes.
    Tang WL; Tang WH; Chen WC; Diako C; Ross CF; Li SD
    Mol Pharm; 2017 Jun; 14(6):1969-1979. PubMed ID: 28460165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a child-friendly oral drug formulation using liposomal multilamellar vesicle technology.
    Al Fayez N; Böttger R; Ghosh S; Nakajima Y; Chao PH; Rouhollahi E; Nguyen A; Cullis PR; Witzigmann D; Li SD
    Int J Pharm; 2022 Sep; 625():122107. PubMed ID: 35964828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
    Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol.
    Basavaraj S; Betageri GV
    Expert Opin Drug Deliv; 2014 Apr; 11(4):493-503. PubMed ID: 24456117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery.
    Tang WL; Tang WH; Szeitz A; Kulkarni J; Cullis P; Li SD
    Biomaterials; 2018 Jun; 166():13-26. PubMed ID: 29529479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
    Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
    Lim HJ; Masin D; McIntosh NL; Madden TD; Bally MB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):337-45. PubMed ID: 10604968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust Microfluidic Technology and New Lipid Composition for Fabrication of Curcumin-Loaded Liposomes: Effect on the Anticancer Activity and Safety of Cisplatin.
    Hamano N; Böttger R; Lee SE; Yang Y; Kulkarni JA; Ip S; Cullis PR; Li SD
    Mol Pharm; 2019 Sep; 16(9):3957-3967. PubMed ID: 31381352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of transition metal-doxorubicin complexes inside liposomes.
    Abraham SA; Edwards K; Karlsson G; MacIntosh S; Mayer LD; McKenzie C; Bally MB
    Biochim Biophys Acta; 2002 Sep; 1565(1):41-54. PubMed ID: 12225851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
    Thomas AM; Kapanen AI; Hare JI; Ramsay E; Edwards K; Karlsson G; Bally MB
    J Control Release; 2011 Mar; 150(2):212-9. PubMed ID: 21094191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
    Erdoğ A; Putra Limasale YD; Keskin D; Tezcaner A; Banerjee S
    J Pharm Sci; 2013 Oct; 102(10):3666-77. PubMed ID: 23897281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
    Al Asmari AK; Ullah Z; Tariq M; Fatani A
    Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics.
    Gkionis L; Aojula H; Harris LK; Tirella A
    Int J Pharm; 2021 Jul; 604():120711. PubMed ID: 34015381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
    Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
    Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and characterization of liposomes containing drug absorption enhancers for optimized anti-HIV and antimalarial drug delivery.
    Kheoane PS; Enslin GM; Tarirai C
    Drug Deliv Transl Res; 2023 May; 13(5):1358-1371. PubMed ID: 36443635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo.
    Tardi PG; Gallagher RC; Johnstone S; Harasym N; Webb M; Bally MB; Mayer LD
    Biochim Biophys Acta; 2007 Mar; 1768(3):678-87. PubMed ID: 17208196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.